These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15171242)

  • 1. WHO and UNAIDS unveil plans for 3 by 5 AIDS programme.
    Rassool GH
    J Adv Nurs; 2004 Jun; 46(5):567-9. PubMed ID: 15171242
    [No Abstract]   [Full Text] [Related]  

  • 2. UNAIDS calls for progress against TB/HIV epidemic.
    AIDS Alert; 1998 Jun; 13(6):suppl 3. PubMed ID: 11365465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.N. drug initiative hits the ground.
    Cadman J
    GMHC Treat Issues; 1998 Jun; 12(6):5-6. PubMed ID: 11365723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for the developing world.
    GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the time for an AIDS-free new generation different in resource-limited and industrialized countries?
    Russo G; Lichtner M; Traditi F; Vullo V
    AIDS; 2009 Jan; 23(3):293-6. PubMed ID: 19114853
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
    Yearby R
    De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral therapy in the developing world.
    Chulamokha L; DeSimone JA; Pomerantz RJ
    J Neurovirol; 2005; 11 Suppl 1():76-80. PubMed ID: 15960241
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of mother-to-child transmission of HIV: treatment options.
    McIntyre J
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):971-80. PubMed ID: 16307509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of mother-to-child transmission of HIV infection.
    Luzuriaga K; Sullivan JL
    Clin Infect Dis; 2005 Feb; 40(3):466-7. PubMed ID: 15668872
    [No Abstract]   [Full Text] [Related]  

  • 12. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment. Study findings show HAART drugs benefit pregnant women.
    AIDS Policy Law; 2007 Oct; 22(19):2. PubMed ID: 18210649
    [No Abstract]   [Full Text] [Related]  

  • 14. Cesarean delivery and perinatal HIV transmission: waiting for definitive data.
    Cohan D
    Clin Infect Dis; 2005 Oct; 41(7):1068; author reply 1068-9. PubMed ID: 16142679
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO's HIV/AIDS strategy under the spotlight.
    Kim JY
    Bull World Health Organ; 2004 Jun; 82(6):474-6. PubMed ID: 15356946
    [No Abstract]   [Full Text] [Related]  

  • 16. An act to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes. United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003. Public Law 108-25.
    United States. Congress
    US Statut Large; 2003 May; 117():711-50. PubMed ID: 16700110
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.
    Hawkins D; Blott M; Clayden P; de Ruiter A; Foster G; Gilling-Smith C; Gosrani B; Lyall H; Mercey D; Newell ML; O'Shea S; Smith R; Sunderland J; Wood C; Taylor G;
    HIV Med; 2005 Jul; 6 Suppl 2():107-48. PubMed ID: 16033339
    [No Abstract]   [Full Text] [Related]  

  • 18. The obstetric face and challenge of HIV/AIDS.
    Guidozzi F; Black V
    Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention.
    Andreotti M; Guidotti G; Galluzzo CM; Mancinelli S; Germano P; Pirillo MF; Marazzi MC; Vella S; Palombi L; Giuliano M
    AIDS; 2007 Nov; 21(17):2360-2. PubMed ID: 18090293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.